Back to Journals » Clinical Ophthalmology » Volume 13

Main Complications of Photorefractive Keratectomy and their Management

Authors Spadea L, Giovannetti F

Received 4 October 2019

Accepted for publication 6 November 2019

Published 27 November 2019 Volume 2019:13 Pages 2305—2315

DOI https://doi.org/10.2147/OPTH.S233125

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Jessica O'Connell

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser


Leopoldo Spadea, Francesca Giovannetti

Eye Clinic, Policlinico Umberto 1, Department of Sensory Organs, “La Sapienza” University of Rome, Rome, Italy

Correspondence: Leopoldo Spadea
Head Eye Clinic, Policlinico Umberto 1, “Sapienza” University of Rome, Via Benozzo Gozzoli 34, Rome 00142, Italy
Tel +39 06 519 3220
Fax +39 06 8865 7818
Email leopoldo.spadea@uniroma1.it

Abstract: Photorefractive keratectomy (PRK) was the first surface ablation procedure introduced for the treatment of refractive errors and has been proven to be effective and safe. In some cases, however, the patient may not be totally satisfied with the final result and retreatment may be necessary. We performed a literature review to describe the main conditions that may arise following PRK that may require retreatment and new promising techniques to allow customized and effective treatments for patients. There is currently no gold standard for retreatment of residual refractive error after PRK. The surgeon must take into account the patient’s history and type of problem when choosing the most appropriate technique. LASIK and PRK are the main options. Haze can be treated with good results with phototherapeutic keratectomy and mytomicin C. High order aberrations and decentration may be addressed with topographically-guided excimer photoablation or with wavefront-guided PRK.

Keywords: photorefractive keratectomy, enhancement, corneal wound healing, regression, haze, decentration, HOA, topographically-guided excimer laser photoablation


Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]